Aim: Background-Nurses and allied health professionals must maintain competence, skills and knowledge through continued education and mandatory training to ensure continued registration with regulatory bodies. Response to changes in health care delivery, advances in medicine, knowledge and technology have placed higher demand for nurses to keep up to date with new practices and policy. The literature suggests that health care organisations who provide ongoing education and training for staff can demonstrate higher levels of staff satisfaction and retention. Education and commitment to staff is a key point in the Nursing and Midwifery Strategy and education should be included in an organisations strategic plan as it infl uences the quality of patient care. Direct links have been made between the quality of patient care and the education of those delivering the care. A requirement of JACIE standards (Joint Accreditation committee of EBMT and ISBMT) is that Haematology Transplant centres provide specialist education in transplant. Aim--Provide regular education to staff of all designations within the Haematology department. -Sessions will be informal, welcoming and varied. -Give staff an opportunity to regularly access education.
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-That staff have evidence of attendance for their personal portfolio. -The department has evidence of providing education in keeping with JACIE standards. -Utilise the skills and experience of the staff within our MDT. -Presentations are accessible and available on the department's intranet site. Method: -A Weekly education programme was developed and circulated to staff within the extended MDT, topics varied and were specifi c to Transplant and Haematology. -A register of attendance was kept. -A certifi cate was given to attendees to be put in their personal portfolio. -An evaluation form was completed; feedback was used in future planning. -Sessions were limited to 30 minutes, repeated and took place when afternoon staff crossed over to ensure maximum attendance. Results: -Evaluation forms from 30 randomly selected sessions were reviewed. -A staff questionnaire was undertaken.
-Results from the evaluations show attendance numbers and staff designation. -Results from the Questionnaire look at staff s response to questions asked. Conclusion: Weekly education sessions have been successfully implemented, staff have access to regular education and the department has evidence of education provision. The staff questionnaire highlights value added to role, improved practice and colleague recommendation. From our research and experience we feel that providing staff education is necessary for keeping staff up to date on changes and developments within the speciality with the benefi t of adding value to individual's role and improving practice. This will impact on the delivery of quality patient care. Disclosure of Interest: None Declared. Aim: This project is part of the paediatric collaboration project between India and Spain to improve the children´s health The pediatric nurses education among other objective and through the Fundación Vicente Ferrer (FVF) which is an NGO (non-governmental development organization) committed to the transformation of one of the poorest and most needy areas of India, Anantapur, and one of the poorest and most excluded communities, the Dalits (untouchables) and tribal groups. It consists of two teams: one Spanish, Fundación Vicente Ferrer (FVF) and one Indian, Rural Development Trust (RDT) that work together.
NO002 SHARING KNOWLEDGE. EDUCATIONAL PROJECTS
We had developed our work as a volunteer pediatric nurse at Bathalapally at the Children's Hospital. Pediatric WARD 1, has 13 beds, the average admissions per months are about 100 patients. Pediatric age: from 3 months to 14 years old. Main diagnosis are: thalasemia, oncologic diagnosis, fever, convulsions, pneumonitis, malaria, dengue, sepsis, dehydratation, mal nutrition, diarrhea, etc. Method: Our task has been focused in assess and improve the knowledge and practice in: Aseptic rules for daily routines, IV lines, venipunctures, catheterization. The importance of proper hand washing and how to dry then in the right way. Weekly routines of checking and cleaning (fridge, trolleys). The way of fi xing peripheral cannulas putting on splints in order to reduce the number of venipunctures. We have also organized the material and drugs for Cardiac arrest. `Cardiac arrest trolley' has been checked, completed and properly organized for WARD 1, 2 and Casualty and a poster has been made in order to standardize it. Education: In order to emphasize this topics we made several lectures, -Prevention of nosocomial infections.
-Hand washing.
-Paediatric emergencies.
-Oxygen therapy.
-International guidelines about several topics have been collected and saved. -Safe injection, infusion and medication vial practice in healthcare. -Pediatric emergencies guideline.
-Guideline for hand hygiene in health care settings. -Operational guideline on facility based management of children with acute and severe malnutrition.
Aim: Nursing practice in hemato-oncology is characterized by dynamic, highly complex care giving. Many patients undergo intensive treatment with (combinations of ) chemotherapy and radiotherapy, immunosuppressive medication and transplantation. They require specifi c nursing competencies. Although there are increasing training opportunities for hematology nurses in the Netherlands, there is no agreement on the knowledge and skills needed. Education for advanced nursing in hematology is not approved by the CZO, the national organization that accredits medical auxiliary education programs and advanced nursing education. Method: To better defi ne and maintain quality standards for advanced hematology nursing we searched on internet and literature for competency descriptions. Found relevant information from Sweden (2009) and UK (2010) along with the nationally recognized description for oncology nurses formed the basis for consultation of Dutch trainers and nurses working in hematooncology. In a series of meetings, the specifi c knowledge and skills for hematology nurse were discussed and described. The resulting concept curriculum was off ered for evaluation to all hematologists and hemato-oncology nurses who are members of the Dutch association, managers of hemato/oncology wards and, patient associations. Results: Using all the information gathered, the SIG Hematology together with various trainers in onco-and hematology has described competences and goals for advanced hematology nursing. Furthermore a curriculum aiming at uniformity of theoretical knowledge and practical skills for hematology nurses is proposed. This will be available for nurses working in inpatient or outpatient setting, both in academic and general hospital in accordance with the quality classification system of HOVON. The curriculum covers nursing care through the entire disease process-diagnosis, treatment, recovery and survival as well as palliative and end-of life care in hematology. Although it concerns mainly hemato-oncological care, the curriculum includes also the basics of benign hematologic care. Examples of topics are: management of combination therapies, complex pharmacotherapy, apheresis, diverse transplantations, infections, GVHD, late effects, improvement of quality of life, psychological support. After broad evaluation, the curriculum will be submitted for approval to the CZO. Conclusion: Special patients need special nurses; high complex care for hematology patients calls for advanced nursing education and practice. The competences and the curriculum described here will help nurses to acquire knowledge through clinical experience and higher education in hematological nursing.
We hope that others will fi nd this useful in planning international hematological nursing education programs that will not only creates a framework for (JACIE) quality and serve the nursing profession, but also improve the quality of care of hematology patients. Aim: Lymphomas represent the most common form of blood cancer and are divided into Hodgkin lymphoma and Non-Hodgkin lymphomas. They aff ect all age groups with increasing incidence in older age. The last few years have seen unprecedented advances in highly active novel therapeutic approaches. This exciting new era was heralded by the arrival of anti-CD20 monoclonal antibodies and immuno-chemotherapy which led to improvements in outcome for patients with lymphoma. Despite these advances, relapsed and refractory disease for many patients still represents a major treatment challenge. Nurses and related health care professionals play a major role in the management and delivery of lymphoma treatment for patients. Continual developments in lymphoma patient management mandates ongoing education of staff working within this fi eld. This educational programme, includes topics such as basic science and treatment of cancers, through to nursing skills in assessing patients with cancer and symptom management. Haematology/Oncology nurses require special educational preparation in order to meet the diverse and complex needs of cancer patients and their families throughout the course of their disease. The structure, training and education of the nursing workforce should provide nurses with sound knowledge and understanding of the care needs of cancer patients and their families. Method: With this in mind, the EBMT-Swiss Nurses Working Group in collaboration with invited experts formed a Lymphoma Working Group, where nurses and patients confronted experience and knowledge in the disease and education requirements and resources available for nurses. On the basis of discussions and evidence on this topic, the Lymphoma Working Group recognised the need to develop a programme of eff ective nurse education which was recognised as one of the most eff ective ways to distribute knowledge to patients and help them to achieve a better understanding of their disease. Results: The result has been a new educational programme for professional nurses and related HCP's, who require theoretical and practical skill development for their role in caring for patients and their relatives living with lymphoma. The aim of this learning programme is to provide nurses and related HCPs with a thorough educational resource in order to support the acquisition of knowledge about this complex group of cancers. The programme has been developed with fl exibility in mind, and as such it has been organised into several separate modules and various formats. 2013 , 80 of 91 (88%) patients that died expectedly in our unit were registered in the SRPC. This questionnaire providing information regarding different quality criteria e.g. information to patient and next of kin, relief of pain, nausea, anxiety and wheezing, documentation of oral care and if the patient died where he/she wished is answered directly after death by the nurse in charge and by review of the medical records. Results: During this period 122 patients died, whereof 26 (21%) patients in the ICU and 4 at other non hematology units, 5 died unexpectedly and 11 were not registered in the SRPC. The majority, 115 patients, died of hematological malignancies, two died of aplastic anemia, one of amyloidosis, two of hemophagocytosis, one of ITP and one patient died of pneumonia. Ten patients died after allogenous stem cell transplantation. M/F ratio was 79/43. Mean age was 65 year (range 19-93). The result from the registration is presented in Table 1 . From the start of registration there is improvement in the following criteria: information to next of kin, relief of nausea and anxiety, documentation of oral care, iv infusions in the last 24 hours and dead without pressure ulcers. For other criteria there is substantial variation from one year to another. Conclusion: Registering patients in the SRPC help us to pay attention to various quality indicators important for good end of life care. Even if we can see improvement in certain areas there are many things that we have to consider in the ongoing work to improve the quality of palliative care at our hematology unit. We note that 26 of our patients died at the ICU, and so far, the ICU are not using SPRC to report patients that die expectedly. It would
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clearly give more validity to the results if more units could register their patients in the SPRC. Disclosure of Interest: None Declared. Method: Review of current practice and meeting with the Legal Department at the hospital was arranged, to discuss the rights for child donors. Meeting with all collaborating staff regarding current and future setting for sibling child donors was held. We discussed: Donor integrity, ethical and legal issues, accreditation standard and future options for information, pre-examination and follow-up for the donor at a diff erent pediatric unit and revise of current written donor information. Results: Manual for child donor process has been created and supported with numbered forms and checklists, including revised donor information. All information will still be sent out by TC. A pediatrician outside the BMT unit is introduced to the donor program; information session, pre-examination and follow-up. (DoH 2002) . In order to make health decisions, individuals need to be supported by appropriate information that is relevant, timely and accredited (DoH 2009). Bone Marrow Transplantation (BMT) is a complex process with immediate and long-term eff ects, which may permanently impair quality of life aff ecting morbidity and mortality. Achieving understanding of the various aspects of long-term recovery is imperative to enable decision-making, rehabilitation and survivorship care-planning. Existing patient information resources concentrated on the transplant process and immediate after care but inadequately addressed long-term management, care, treatment of late eff ects and survivorship needs. We aimed to develop an information resource in response to patient and healthcare professional demand that would meet the complex and diverse needs of long-term BMT survivors. Method: Funding was secured from the Anthony Nolan charity to support the project through the development phase, publication and distribution of the resource for 1 year. The authors considered the views, opinions and suggestions of patients, their carers, medical staff , nursing colleagues and members of the multi-disciplinary team and these were incorporated at each stage. Members of relevant professional bodies (EBMT Nurses' Group and BSBMT) reviewed the fi nal draft. Results: The book was launched at the 7th EBMT Patient and Family Day, London 2013 where it was received by patients and their carers and during the main meeting for doctors, nurses and healthcare professionals. It is available free of charge as a booklet or download and has reached a circulation of almost 4000 copies over the last 8 months. Feedback has been overwhelmingly positive from all users; the content is understandable, up to date and written in an empathic style. For patients, it is fi lling the information void intended, while for healthcare professionals, it is being used as both an information and education resource. Conclusion: Like its 'sister' publication, the Seven Steps: blood and marrow transplantation, The Seven Steps: The next steps, is becoming recognised as a standard text for BMT recipients and is fully endorsed by those involved in their care. Feedback demonstrates that this is a much needed and valued resource and as we approach the end of Year 1, we are delighted to have been pledged further Anthony Nolan funding to support the ongoing publication and distribution of the booklet. Aim: A supportive family environment enhances the capacity of patients to adapt to their illness and treatment, like the hematopoietic stem cell transplantation (HSCT). Caregivers, like patients, show a diff erent attitude in their ability to cope with the impact of a severe diagnosis and to fulfi ll the patient's need. Therefore, increased understanding of the interrelationships between the family's and patient's responses to illness is needed to take care of the patient. This study is meant to investigate the caregivers role and needs and their perception of patients' emotions and needs, with the purpose of understanding how to improve the caregiver capability to be supportive and engaged with the patient in facing the HSCT. Method: In January-October 2012 48 semi -structured interviews with caregivers of patients undergoing HSCT in San Raff aele Hospital in Milan were conducted before HSCT to assess: -Caregivers' perception of patient's emotions and needs; -Caregivers' perception of their own emotions and needs; -Caregivers' role in patient's assistance. The interviews were analyzed by SPSS statistical software evaluating the agreement among ratings between multiple judges.
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Results: The analysis of the results shows a good agreement among ratings of independent judges (Fleiss k = 0.682). Caregivers describe their role as primarily characterized by the management of physical and practical needs and by the identification of patient's symptoms of emotional distress. Although caregivers describes patients to be confi dent and prepared to face the transplant experience, they identify the psychological support as the main need for patients' during HSCT: caregivers described themselves as able to recognize patients' distress, but enable to give them the appropriate emotional support, also as a result of their anxiety before the HSCT, or in the subsequent patient's assistance. Therefore the need to receive more information about how to manage patients' emotions emerged as caregivers' main necessity, considering this also supportive for their own worries. Conclusion: The need to receive support in helping patients' to face emotionally the transplant experience stands out as the main necessity for caregivers. Specifi c implications for practice include the importance of caregiver education in the area of patient-care information and of assessment and intervention to meet caregiver psychological needs. This suggests the outstanding importance for the HSCT team to plan interventions to reduce the caregiver burden and anxiety making them able to off er the emotional support the HSCT patients require, especially according to critical time periods of the patients' hospitalization, when emotional distress is more likely to occur. Aim: To describe an overview of issues addressed in our unit's moral deliberation group and the subsequent impact on practice. Method: Annually in the LUMC, approximately 40 children undergo allogeneic hematopoietic stem cell transplants (SCT) for either malignant (55%) or non-malignant diseases (45%). Features of SCT include lengthy admissions, complex treatments and risk of serious complications including death. To address the ethical dilemmas encountered by families and caretakers we established in 2009 a structured moral deliberation group to facilitate discussion and improve care. Multidisciplinary monthly meetings were scheduled and chaired by a Health Related Ethics and Law expert. A specialist nurse with ethics training prepared cases for discussion. All medical and non-medical personnel were invited to participate. Results: Between October 2009 and October 2013, 31 meetings took place. In 16 meetings individual patient concerns were discussed and in the remainder more general themes (Table) . Participation increased over time from initially 11 to on average 20 participants. Over the years this has resulted in interdisciplinary exchange of ideas, increased understanding of decision making and reduced frustration and stress among the different SCT team members. The group has discussed patient's `good medical care' , clarified criteria for discharge and responsibilities post-SCT and changed focus on `how' and no longer `if' SCT can be undertaken in cases of complicating psychosocial circumstances. We also established a new workgroup to review parental involvement and confirmed the importance of routine pre-SCT psychological assessment to explore family coping mechanisms. Aim: The aim of this study was to investigate paediatric nurses' perception relating to the factors which can infl uence the process of negotiation between paediatric nurses and Stem Cell Transplant paediatric patients and their parents in the daily care. Method: The study due to its exploratory aim required a qualitative design, with in depth interviews, and a constructivist approach. To obtain trustworthiness, of qualitative data (which in quantitative research could be considered as validity and reliability) of the fi ndings, we decided to adopt the Lincoln and Guba's `Four criteria ' (1985) : credibility, confi rmability, transferability and dependability. Content analysis was applied to all verbatim transcriptions. The current study was guide by `the Cultural Negotiation Model' (Engebretson and Littleton' , 2001) since the paediatric patients (and their parents) and nurse, each bringing their respective knowledge and cultural orientations, enter into a partnership relationship that is best described as cultural negotiation. Results: The results showed four categories as important: communication, attitudes, specifi city and organizational issue. The process of negotiation requires diff erent skills and diff erent approaches. Communication is crucial since the admission of the patient in the SCT Unit. Conclusion: The qualitative approach has been useful to point out categories which can underline points of future improvement and research. The study can improve healthcare attitudes and knowledge regarding the process of negotiation with the parents and children in the SCT Unit. Disclosure of Interest: None Declared. Aim: Background: Hematopoietic stem cells related donation raises ethical and clinical questions such as how `to take care' of the donor? Are the teams involved in patients' care able to consider some specific questions raised by related-donation and its impact on family relationships? Current research show that 70% of American and 57% of European transplant teams are involved in one way or another with donors information, informed consent and the stem cells collection process. The latter underlines an obvious problem of conflict of interest regarding the same transplant team taking care both of the patient and donor. The Bone marrow transplant coordinating nurses (BMT-CN) have a main role in informing potential donors, organizing HLA tests, pre-donation work-up, and stem cells collection as well as in supporting related donors along the donation process. Aim: Our exploratory study aimed to better understand BMT coordinating nurses' perceptions on related donors' care issues. Method: 29 BMT adult units' nurses coordinators were sent a questionnaire containing open questions related to: Professionals' data: age, length of professional experience; Donation procedures: separate teams/caregivers or not for recipients and donors; organization of family members' information and HLA tests; modalities of donors' information about the donation process (support materials, professionals involved in this process); social and fi nancial support; donors' follow up. Professionals' experience regarding: donation organization; nurses' rule and diffi culties in related donation process; donors' problems; improvement of related-donation issues. Results: 20 BMT-CN replied to the questionnaire of whom 50% obtained their nursing diploma before 2000 and have been working in Hematology units for more than 10 years, while their professional experience as BMT-CN ranged between 2 and 5 years. Regarding the donation process organization, 50% of transplant teams were also involved in patients' and donors' care. Information about donation preceded HLA tests in 75% of cases, but was considered as insuffi cient in 25% of these situations. Most of the time, HLA tests' results were fi rst announced to patients, while donors had a medical consultation only at time of the pre-donation work-up. None of the transplant teams organised a post-donation consultation, but some of them (n=13) provided a follow up by phone or through a questionnaire. Finally, the BMT-CN highlighted donors' psycho-social diffi culties in donation experience, family confl icts, ambivalent feelings, understanding of donation and transplantation process, etc. Conclusion: BMT-CN perceptions of stem cells donation show that many ethical and clinical problems are still yet to be taken into Aim: Caring for patients receiving in-patient treatment for haematological malignancies involves systematic planning and organisation of care in order to ensure patient safety, increase satisfaction and optimise resources. Clinical care pathways can help in achieving this goal. They are defi ned as complex interventions for the mutual decision making and organisation of care processes for a well-defi ned group of patients during a well-defi ned period. To improve clinical and organizational aspects in nursing care of haemato-oncology patients by implementation of clinical care pathways. Method: A project to develop and introduce care pathways in the management of haemato-oncology patients was devised by the senior nursing team of the Institute, involving experienced healthcare professionals providing care for SCT patients (including nurses, physiotherapists and dieticians). The scope of the clinical pathway was defi ned and specifi c patient interventions which were felt could benefi t from care pathway planning were identifi ed. These included hospital admission for autologous and allogeneic SCT or a high dose chemotherapy regimen (ICE, ESHAP, High dose methotrexate, IGEV, CODOXM-IVAC). A review of the literature was performed to identify existing care pathways for this type of treatment/patient. Where no care pathway was found, the literature was used to provide to support an evidence based development of the pathway. Results: Clinical pathways were developed for each of the specifi c patient interventions listed above, and they have been approved and implemented within the department. They provide information required for a multidisciplinary based planned programme of care for in-patients. Each care pathway outlines the steps of care, day by day, including the initial evaluation of the patient, diagnostic tests, potential side eff ects of treatment, referrals, discharge planning etc. They provide guidance for nurses by ensuring continuity of care, support nurses with less experience in the fi eld as an educational tool, giving a clear framework for care provision, and can be used as an aid in workload planning. These pathways are also discussed with patients in order to facilitate their understanding of the care provided, and ensure expectations are realistic in terms of their progress through the in-patient stay. Conclusion: The implementation of care pathways has ensured a multidisciplinary approach to the introduction and dissemination of evidence based medicine in patient care. It has provided a standardised approach to patient care within specifi c situations, which is part of the patient documentation and can then be subject to clinical audit, facilitating the evaluation of care provided. Further development of clinical pathways is currently underway, with a parallel patient diary in which patients are given information regarding each of the daily steps in the pathway and rationale. Disclosure of Interest: None Declared. Aim: Patients treated with allogeneic hematopoietic stem cell transplantation (HSCT) to varying extents report having an altered sex life and several sexual changes. We have limited knowledge of how the sexual changes and their consequences are experienced by patients following allogeneic HSCT. The objective of this study is to generate insight into patients' experience of their sexuality one year after treatment with HSCT from a biopsychosocial perspective. Method: A qualitative study with semi-structured in-depth interviews. The respondents (n=9) are recruited from the Department of Haematology at Rigshospitalet, Copenhagen University Hospital one year after treatment with HSCT. The interviews are analysed from a phenomenological-hermeneutic perspective. Results: Three main themes were identifi ed: a changed body, mastering one's own life, identity and sexuality. Bodily changes led to physical limitations or negative body image which directly or indirectly resulted in sexual dysfunction. The respondents deprioritised their sexual needs, because their life situation had made survival paramount. Their experience of changed social roles, both in family life and their social network, aff ected their selfimage and identity. Conclusion: The informants experienced physical, psychological and social changes which aff ected their sexuality and identity in varying extents. As health professionals we have a responsibility towards the patients with regard to improving their options for preventive and therapeutic intervention in relation to the identifi ed changes, which may aff ect their sexuality and sexual life. Future intervention studies could focus on preventive interventions within each of the three identifi ed main themes. Disclosure of Interest: None Declared. Aim: Since April 2002, in response to the growing indications of allogeneic transplantation after reduced-intensity conditioning (RIC) and because of a lack of beds, the physicians propose systematically an `outpatient' support. We conducted a retrospective analysis of 160 patients (April 2002 -July 2013 to demonstrate the feasibility, the interest and the safety of these outpatient cares. Method: All patients eligible for RIC were included, regardless of their age (49 years on avarage), disease (89 a-cute leukemia, 42 lymphoid pathologies, 26 myeloma, 3 others), comorbidities, distance or caregivers at home. The main conditioning is a Slavin like (fl udarabin, busulfan and thymoglobulins), GVHD prophylaxis with cyclosporin and a basic anti-infectious prophylaxis. Patients are hospitalized during 7 days and return home at D+1 if they feel good. From the pre-transplant assessment, patient and family education is provided by the physician, the transplant coordinator, nurses and dietician before and during hospitalization and in Day Hospital. It mainly concerns the necessary monitoring, low bacterial food, protection against infections, taking cyclosporin. Upon discharge, patients are systematically reviewed by a transplant physician twice a week during the fi rst three weeks at the Day Hospital. Unless complications, after D+28 the monitoring will be once a week. If necessary, a hematologist can be reached anytime and readmission is possible easily in the oncology-hematology center. Results: The results at D+28 show a neutrophil recovery on 15, 8 days on average. 38 patients required transfusions. Only 12 patients in 11 years remained hospitalized after allograft; 37 patients/23% were readmitted mostly for febrile neutropenia. All the patients are alive at D+28 and no deaths are related to early discharge home. On the other hand, the fi nancial gap isn't significant and doesn't justify a prolonged hospitalization detrimental of the quality of life of the patient. Also, early home discharge reduces the duration of hospitalization, optimizes the management of beds of our small unit and so to treat a greater number of S393 patients without endangering patients or increasing costs. Shortterm hospitalization also improves better acceptance of the graft after often prolonged and painful treatments before and off ers patients a better quality of life at home. However, a larger and randomized study, comparing outpatient versus inpatient care and an accurate costing, would be more conclusive. Conclusion: Thanks to serious monitoring in Day Hospital and good education upstream, early home discharge after a RIC in allogeneic transplantation is feasible, safe and increases the intake capacity for allograft, while reducing costs and signifi cantly improving the quality of life of patients. Disclosure of Interest: None Declared. Aim: To determine research priorities for EBMT nurses group members, comparing results with those from a 2006 survey. Method: An online questionnaire was administered to 961 nurse members, collecting biographical data and data relating to nursing research (infl uence on practice, performance of nursing research, perceived barriers, and research training). Responders were asked to rate their research priorities using a scale -1 (least important) to 5 (most important). Results: In total, 159 responses were received (16.5%), most from nurses with 13-15yrs experience in stem cell transplantation (SCT) (26%). Nursing research was reported by 81% to infl uence their practice and 27% reported frequently participating in research activities. Nearly half (47%) had performed or were performing research. Three quarters (76%) considered initiating nursing research. The most common barrier to research was limited time (76%). Half of the respondents had undertaken research training, and 80% reported they would benefi t from training in research methodology, with preference for EBMT study days, modules on the EBMT website or on-line support. Research priorities: In 'management of nursing issues' , highest priority was given to supportive care & symptom management Aim: Patients after stem cell transplantation (SCT) need to adhere to medications and execute a healthy lifestyle to prevent morbidity and mortality. Few studies exist on adherence to health behaviours in SCT. This study aimed (1) to determine the prevalence of non-adherence to health behaviours in SCT survivors and (2) to compare them with matched controls from the general population. Method: This cross-sectional comparative study enrolled a convenience sample of 376 patients from 2 Swiss centres who were at least 1 year post allogeneic SCT [54.8% males; mean age 50.4 years (SD=12.8); median 7 years post SCT (IQR=8.75), 40.6% chronic Graft versus Host Disease]. Controls were derived from the Swiss Health Survey 2007 (SHS), a nationwide representative study including 18760 participants, using propensity score matching based on gender, age, educational status, region and level of urbanization. Physical activity, dietary habits, alcohol consumption, smoking, vaccination, and sun protection were assessed by self-report items derived from the SHS. Medication non-adherence to immunosuppressants (IS) was measured in STC patients only using the BAASIS © , a validated self-report instrument measuring implementation (taking & timing, drug holidays, dose reduction), discontinuation and overall non-adherence of the immunosuppressive regimen. For patients taking other medications an adapted version of the BAASIS © was used. Results: Compared to the general population, patients were more likely to report inactivity (26.8% vs. 12.5%; p=<0.001), had a lower consumption of daily vegetables (≥3 pieces: 10% vs. 21.6; p<0.001), fruits (≥3 pieces: 6.5% vs. 10.6%; p<0.001) and were less likely to have a weekly fi sh dish (31.2% vs. 60.9%; p<0.001). More patients consumed dairy products on a daily basis (92.5% vs. 62.9%; p<0.001) and were less likely to eat meat on more than fi ve days per week (17.8% vs. 26.6%; p<0.001) . Patients reported greater use of sun protection (94.5% vs. 85.3%, p<0.001) and received a fl u vaccine more frequently in the last year (26.8% vs. 12.5%; p<0.001). Less patients smoked (13.4% vs. 35.4%; p<0.001) and consumed alcohol (81.8% vs. 87.2%; p<0.001) . Those who drank alcohol reported a lower number of consumed alcohol beverages per week (median 1.5 (IQR 4) vs. median 4.5 (IQR 10.3); p<0.001). Overall immunosuppressive medication non-adherence occurred in 65.7% of patients taking IS, with the greatest problems occurring with timing (61.2%) and medication intake (33.3%). 37.6% of patients taking other medications were non-adherent. Conclusion: Although patients in general are leading a healthier lifestyle compared to the general population, high prevalence of physical inactivity, nutritional issues, vaccination problems and medication non-adherence were observed that warrant appropriate self-management interventions. Disclosure of Interest: None Declared. Aim: We investigated pain management, enteral nutrition intake, parenteral nutrition and days of hospital stay in myeloablative allogeneic haematopoetic stem cell transplant (HSCT) patients receiving 3 fractions of each 4 Gy per day total body irradiation (TBI) versus 6 fractions of each 2 Gy TBI, two fractions per day 6 hours apart. Data indicates that hyperfractionated TBI may reduce mucositis in HSCT patients. Oral and gastro-intestinal (GI) mucositis results in pain, vomiting, diarrhea and diffi culty in getting suffi cient enteral nutrition. To prevent malnutrition we routinely supply with a naso-gastric feeding tube and/or parenteral nutrition. A criterion at our institution for discharge is that the patients are able to take suffi cient food and drink orally, besides neutrophil take etc. Pain from mucositis is initially managed with orally opiates, and if this is insuffi cient, morphine is administered by an intravenous (IV)-pump, but it is also evident that use of iv opiates prolong the hospital stay. Method: Sixty-six consecutive HSCT recipients, 32 TBI-3 and 34 TBI-6 were analyzed with respect to days of parenteral nutrition S395 (PE), days on enteral nutrition (EN) both food taken orally and feeding tube, use of intravenous opiates and days to discharge. Data were recorded from day 0 to day 20. SPSS ver. 19 has been used to process data. Results: The two groups were statistically comparative. Gender was distributed with 12 female/20 male in the TBI-3 group and 13 female/21 male in the TBI-6 group . The median age was 40.5 years for the TBI-3 group and 41.0 for the TBI-6 group. [0] in TBI-6 patients, p=0.6. In both the TBI-3 and TBI-6 patients 7 was transplanted with MRD, 25 with MUD and furthermore 2 TBI-6 patients with UCB, p=0.9. The median number of days on PE nutrition from day 0 to 20 was 15,5 in TBI-3 patients, versus 9,5 days in TBI-6 patients, p=0.04. For enteral nutrition the median number of days was 13 in the TBI-3 group and 21 in the TBI-6 group, p=0.03 Use of morphine IV-pump was signifi cantly less in the TBI-6 group with only 14 patients as compared to 22 patients in the TBI-3 group, p=0.03. Furthermore, the median days to discharge was 28 in the TBI-3 group versus 25 in the TB-6 group, p=0.02, without a diff erence in days to PMN take with 23 days in TBI-3 patients against 20 days in TBI-6 patients, p=0.2. Conclusion: We fi nd that the less severe oral and gastro-intestinal mucositis after hyperfractionation of TBI results in signifi cantly higher intake of enteral nutrition, signifi cantly lower use of IV opiate and this contributes to 3 days earlier discharge of patient receiving 6 fractions of TBI than patients receiving 3 fractions of TBI. Disclosure of Interest: None Declared. Aim: Fluctuations in electrolyte levels is often seen in patients undergoing peripheral blood stem cell (PBSC) collection. This is due to possible citrate toxicity and might require interventions during the apheresis procedure such as substitution of calcium. This retrospective audit evaluates the changes in electrolyte levels before and after PBSC collection. The aim was to perform an audit of the levels of magnesium, potassium and calcium before and after PBSC collection. We also wanted to evaluate sampling routines and see if measures were taken when the electrolyte levels were out of range. Method: Data from January 2010 to July 2013 was collected retrospectively from patients undergoing PBSC collection for a planned autologous stem cell transplant. Plasma levels of magnesium, potassium and calcium before apheresis were compared with levels after one day of apheresis (n=103) and after two days apheresis (n=52). The electrolyte levels after apheresis were also graded according to Common Terminology Criteria for Adverse Events (CTCAE). Results: A decrease in magnesium was seen in 93% of the sampled patients in day 1 of apheresis and in 87% of the patients in day 2. 82% were below the reference interval in day 1 and 96% in day 2. 12% of the patients had a CTCAE grade >1 hypomagnesemia in day 1 and 28% had a grade >1 hypomagnesemia in day 2. A decrease in potassium was seen in 97% of the patients in day 1 of apheresis and in 55% in day 2. 93% were below the reference interval in day 1 and 98% in day 2. After one day of apheresis 38% of the patients had a grade 3 hypokalemia and after two days 51% had a grade 3 hypokalemia. An increase in calcium was seen in 100% of the patients after both days of apheresis. 78% were above the reference interval in day 1 and 75% in day 2. 10% of the patients had a grade >1 hypercalcemia after both days of apheresis. It was also noted that magnesium levels were never monitored in 11% (day 1) and 14% (day 2) of the patients, indicating that the prescribed sampling routines were not followed.
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NO015 PATIENTS` EXPERIENCE OF SEXUALITY 1-YEAR AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
NO016 EARLY DISCHARGE AFTER ALLOGRAFT WITH REDUCED-INTENSITY CONDITIONING : FEASIBILITY AND COST
Oral Session 5 NO017 NURSING RESEARCH PRIORITIES: A SURVEY FROM THE EBMT NURSES GROUP (EBMT-NG) RESEARCH SUB COMMITTEE
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NO022 CHANGES IN ELECTROLYTE LEVELS AFTER LEUKAPHERESIS
Conclusion: A signifi cant amount of the patients had a decrease in their potassium levels which suggests that a prophylactic intervention might be needed before the start of apheresis. To our surprise an increase in calcium was seen in all patients after both days of apheresis. This suggests that the routines for prophylactic calcium substitution before and during apheresis need to be revised. Close monitoring is of great importance to identify variations in electrolyte levels in patients undergoing PBSC collection. The missing data on magnesium levels in some of the patients shows the importance of standardized sampling procedures to ensure that all patients are monitored according to guidelines. Disclosure of Interest: None Declared. Aim: Guidelines from the Surviving Sepsis Campaign recommend that patients with febrile neutropenia should be administered antibiotics within an hour of hospital admission in order to minimise potential complications. The Christie implemented a patient group directive (PGD) in 2010 so that nurses could administer appropriate intravenous antibiotics within one hour of suspected sepsis to patients on the Haematology and Transplant Unit (HTU) as they represented a high risk group. This treatment within the hour is referred to as 'door to needle' (D2N) time. An audit was carried out to determine if management of suspected neutropenic sepsis was appropriate and responsive, looking specifi cally whether treatment was commenced within an hour. The fi rst audit was carried out 3 months following the introduction of the D2N policy, this is a follow up audit. Method: Data was collected using a pre designed audit tool over a 3 month period. The data was collected on all patients that had an initial suspicion of neutropenic sepsis or suspected sepsis that were inpatients on the HTU. Data was collected by 2 Staff Nurses using multiple sources such as MEDWAY (patient electronic notes), Patient written clinical notes, PACS (radiology). The ward nursing and medical staff where not informed of the audit was taking place, therefore a 'true' data sample could be collected of practice on the ward. Results: -62 Incidences were recorded, with an individual patient count of 35.
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-The largest group were patients with Multiple Myeloma having a Melphlan autologous stem cell transplant (ASCT) (18%).
-The overall door to needle was achieved in 63% of all incidences. 22 patients at the time of sepsis did not receive antibiotics <1 hour.
-When antibiotics were given from prescription only 51% achieved the D2N of <1 hour.
-In contrast, when the PGD was used, 86% achieved the D2N of <1 Hour. Conclusion: It is noted that there are several reasons why antibiotics were not given within the D2N 1 hour time. However, overall one of the main delays was that Junior Medical Staff were unsure of the sepsis protocol. The Nurses also felt that the PGD Protocol was only used between hours 21.00-08.00. Therefore, they waited for review by medical staff if they were already present on the ward at the time of suspected sepsis. Therefore, we recommend that the PGD initiative is to be used at all times on the ward, including when medical staff are present. 2 Yearly updates of Nursing Staff to re-iterate PGD protocols and practice. Review of Sepsis Protocol so that guidelines are as clear as possible for all members of staff . The highest group of patients that presented were having a Melphalan ASCT. This group of patients are often older with one or more co-morbidity. Therefore, we recommended more MDT Management and support from all members of staff . Disclosure of Interest: None Declared.
